Concepedia

Douglas Kalvin

DK

Statistics

Publications

17

Citations

613

H-Index

15

Active since

1984

Affiliations

Abbott Fund(Current)

University of Michigan

Abbott (United Kingdom)

Abbott (United States)

Institute of Medicinal Plant Development

Douglas Kalvin is an author at Abbott Fund specializing in medicinal chemistry, drug discovery, and pharmacology.

Publications per year

1984–2011

17

Publications

17

Thrombospondin-1 Mimetic Peptide Inhibitors of Angiogenesis and Tumor Growth:  Design, Synthesis, and Optimization of Pharmacokinetics and Biological Activities

Fortuna Haviv, Michael F. Bradley, Douglas Kalvin et al. · Journal of Medicinal Chemistry · 2005 · 138 citations

, , +14

Microwave-Assisted Synthesis Utilizing Supported Reagents:  A Rapid and Efficient Acylation Procedure

Daryl R. Sauer, Douglas Kalvin, Kathleen M. Phelan · Organic Letters · 2003 · 51 citations

, , +15

Novel and potent 3-(2,3-dichlorophenyl)-4-(benzyl)-4H-1,2,4-triazole P2X7 antagonists

William A. Carroll, Douglas Kalvin, Arturo Perez Medrano et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 50 citations · Full text

, , +6

Development of sulfonamide compounds as potent methionine aminopeptidase type II inhibitors with antiproliferative properties

Megumi Kawai, Nwe Y. BaMaung, Steve Fidanze et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 48 citations · Full text

, , +12

Potent and Selective Non-Cysteine-Containing Inhibitors of Protein Farnesyltransferase

David J. Augeri, Stephen J. O’Connor, Dave Janowick et al. · Journal of Medicinal Chemistry · 1998 · 43 citations · Full text

, , +10

1–5 of 17